New bulletins: antimicrobials, carbon impact, and overprescribing
We’re continuing to develop new outputs to best support our stakeholders across the country, and today we’ve published three new bulletins:
- Antimicrobial prescribing across the North of England. This bulletin provides an update on the current primary care antimicrobial prescribing trends at ICS level in the North of England, specifically focusing on primary care prescribing.
- Reducing the carbon impact of inhalers across the North of England. This bulletin provides baseline figures on the current Inhaler Carbon Footprint at ICS level in the North of England, so that systems can identify the level of response to be undertaken.
- North of England Integrated Care Systems; Overprescribing. This bulletin provides an update on key primary care prescribing trends in the North of England which relate to overprescribing, incorporating polypharmacy.
You can find all three on the bulletins page. We’d welcome any feedback on these new publications, including input on how often they should be refreshed. Get in touch at nuth.nyrdtc.rxsupp@nhs.net.
September newsletter
Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net
This month’s edition covers new labelling requirements for sennosides, changes to the NHS community pharmacy contract, National guidance on blood testing following shortages, and inclisiran in primary care. It also continues a series of spotlight articles on our prescribing data reports; this month takes a look at our prescribing bulletins.
July newsletter
Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net
This month’s newsletter covers our new website, the latest healthcare professional letter on sodium valproate, and an update on the use of chloramphenicol eyedrops in children. It also continues a series of spotlight articles on our prescribing data reports; this month take a look at our Financial Headlines.
New website launch
The RDTC are proud to share our newly updated website. The new site is streamlined to make it easier for you to see everything we produce, and find exactly what you need with a few clicks.
You can visit the site home page to find out more about all of the services hosted by the centre, or head to the Prescribing Support landing page to take a look at the new layout for our content. The new layout allows you to:
- Click on a topic to see everything we produce in that area, from prescribing data analysis to evidence evaluation.
- Click on “search publications” to do some finer searching, filtering outputs by topic and type to find exactly what you need.
We hope you’ll find the new layout intuitive and easy to use, but don’t hesitate to send us an email or a Twitter message if you have any problems.
You’ll need to re-register using the form at this link to download files, but the form is quick and easy.
We welcome all feedback; please get in touch at nuth.nyrdtc.rxsupp@nhs.net
Great North Pharmacy Collaborative Conference
The Great North Pharmacy Collaborative Conference was held on Friday 9th July, and the team at the RDTC were pleased to attend. The event was held virtually this year, and the theme was Technology: the great pharmacy enabler. The RDTC team submitted four posters, including three from the prescribing support team.
Our posters were:
- The successes and challenges of remote working in a Regional Medicines Information Centre during the COVID-19 pandemic
- Quantification of Respiratory Inhaler Carbon Footprint in primary care prescribing
- Impact of Flash Glucose Monitoring Prescribing on outcomes in people with Type 1 diabetes mellitus (T1DM)
- Prescribing data (ePACT2) models of ‘regular’ and ‘long term use’
You can view these alongside the rest of the great posters on the AHSN website. Congratulations to the three winning posters, and we look forward to next year’s event!
May newsletter
Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net
January newsletter
Prescribing support newsletters aim to inform readers of work done by the unit and work in progress, to help tailor local work plans and highlight any ‘topical’ issues in prescribing or medicines management.
If you have any suggestions for future topics for the newsletter, then please contact nuth.nyrdtc.rxsupp@nhs.net